IonQ Stock Slips as Quantinuum’s $1.68B IPO Gives Investors a Yardstick for Valuing Quantum Plays

Quantinuum's Nasdaq debut under ticker QNT raised $1.68B, pressuring IonQ shares despite strong revenue growth and $3.09B cash reserves.

The quantum computing sector entered a new chapter on Thursday as Honeywell’s spin-off Quantinuum made its Nasdaq debut under the ticker QNT, pricing 28 million shares at $60 each. The $1.68 billion capital raising instantly reshuffled the competitive landscape and sent IonQ’s Frankfurt-listed shares sliding 4.76% to €55.97 – the sharpest single-day drop in weeks.

The pullback came from a lofty perch. IonQ had rallied 43% in the previous 30 days and was trading 42.44% above its 50-day moving average of €39.29. Year to date the stock still shows a gain of 40.28%, and it sits 147.65% above the 52-week low of €22.60 hit in March. But with an annualised 30-day volatility of 159.77%, the equity is hypersensitive to any fresh news in the quantum space.

Quantinuum’s listing provides the first direct publicly traded peer for IonQ, giving fund managers a clear benchmark for comparing revenue growth, cash burn and technological maturity. The immediate reaction suggests that IonQ’s premium multiple – currently around 139 times trailing revenue – is facing a fresh set of questions.

A milestone overshadowed

The sell-off came despite IonQ having just crossed a symbolic threshold. It became the first quantum computing company to book annual GAAP revenue above $100 million. In the first quarter, revenue surged 755% year on year to $64.7 million, with management forecasting $260 million to $270 million for the full year and $65 million to $68 million for the second quarter.

That top-line momentum, however, runs alongside deep operating losses. Adjusted EBITDA is expected to be between negative $310 million and $330 million for 2026. In 2025 the operating loss topped half a billion dollars. Earnings per share of minus $0.34 missed analyst estimates. Research costs ballooned to $125.7 million and general expenses to $88.6 million – a cash-burning profile typical of early-stage quantum companies.

IonQ’s balance sheet provides a cushion. After an October capital raise, it held roughly $3.5 billion in liquidity. That figure stood at $3.09 billion at the end of the first quarter, enough to fund operations for at least 12 months. In a market now closely watching Quantinuum’s cash position, that war chest is a critical differentiator.

Expansion plans and competitive heat

The company is racing to commercialise its technology. A new research centre in Boulder, Colorado, serves as the heart of its hardware strategy, and IonQ aims to deliver its first commercial quantum system by the end of 2026.

But the competitive field is widening. Microsoft has set its sights on a scalable quantum computer by 2029, while Rigetti recently secured fresh grant funding. Quantinuum’s public listing now adds a fully capitalised rival with Honeywell’s industrial backing.

Analysts are split on IonQ’s valuation. Rosenblatt maintains a price target of $100, while Needham and Benchmark have trimmed their expectations to $65. With the stock still trading well below its October high, the next few sessions will reveal whether investors see IonQ’s revenue story as enough to justify its current multiple – or whether the new yardstick from Quantinuum triggers a deeper repricing of the entire sector.